1,200
Participants
Start Date
July 12, 2018
Primary Completion Date
July 31, 2020
Study Completion Date
September 30, 2020
Ulipristal Acetate
UPA Tablet
Levonorgestrel
LNG Tablet
Levonorgestrel
LNG Tablet (x2)
RECRUITING
Bellevue Hospital Center, New York
NOT_YET_RECRUITING
Columbia University, New York
NOT_YET_RECRUITING
University of Pittsburgh/Magee Women's Hospital, Pittsburgh
RECRUITING
University of Pennsylvania, Philadelphia
NOT_YET_RECRUITING
Johns Hopkins Bayview Medical Center, Baltimore
RECRUITING
Eastern Virginia Medical School, Norfolk
RECRUITING
Essential Access Health, Los Angeles
NOT_YET_RECRUITING
University Hospitals of Cleveland MacDonald Women's Hospital, Cleveland
RECRUITING
University of Cincinnati-Holmes Hospital, Cincinnati
NOT_YET_RECRUITING
University of Chicago, Chicago
NOT_YET_RECRUITING
University of Colorado, Denver
NOT_YET_RECRUITING
University of Utah, Salt Lake City
RECRUITING
University of California, San Francisco, San Francisco
RECRUITING
University of California, Davis, Sacramento
RECRUITING
University of Hawaii, Honolulu
RECRUITING
Oregon Health Science University, Portland
RECRUITING
Planned Parenthood League of Massachusetts, Boston
NOT_YET_RECRUITING
Women & Infants Hospital of Rhode Island, Providence
Lead Sponsor
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
NIH
Premier Research
OTHER